Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 385

1.

Prognostic Impact of Renal Dysfunction Does Not Differ According to the Clinical Profiles of Patients: Insight from the Acute Decompensated Heart Failure Syndromes (ATTEND) Registry.

Inohara T, Kohsaka S, Sato N, Kajimoto K, Keida T, Mizuno M, Takano T; ATTEND Investigators.

PLoS One. 2014 Sep 8;9(9):e105596. doi: 10.1371/journal.pone.0105596. eCollection 2014.

PMID:
25197833
[PubMed - in process]
Free PMC Article
2.

Nesiritide fails to reduce the mortality of patients with acute decompensated heart failure: An updated systematic review and cumulative meta-analysis.

Yan B, Peng L, Zhao X, Chung H, Li L, Zeng L, Ong H, Wang G.

Int J Cardiol. 2014 Aug 23. pii: S0167-5273(14)01623-4. doi: 10.1016/j.ijcard.2014.08.078. [Epub ahead of print] No abstract available.

PMID:
25183537
[PubMed - as supplied by publisher]
3.

Is there still a role for low-dose dopamine use in acute heart failure?

Torres-Courchoud I, Chen HH.

Curr Opin Crit Care. 2014 Oct;20(5):467-71. doi: 10.1097/MCC.0000000000000133.

PMID:
25137402
[PubMed - in process]
4.

Natriuretic peptides and cerebral hemodynamics.

Guo S, Barringer F, Zois NE, Goetze JP, Ashina M.

Regul Pept. 2014 Aug 6;192-193C:15-23. doi: 10.1016/j.regpep.2014.07.003. [Epub ahead of print] Review.

PMID:
25107278
[PubMed - as supplied by publisher]
5.

Renal Subanalysis of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF): The End of Nesiritide as a Cardiorenal Therapeutic?

Testani JM.

Circulation. 2014 Sep 16;130(12):936-8. doi: 10.1161/CIRCULATIONAHA.114.012076. Epub 2014 Jul 29. No abstract available.

PMID:
25074508
[PubMed - in process]
6.

Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure: Results From the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).

van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA.

Circulation. 2014 Sep 16;130(12):958-65. doi: 10.1161/CIRCULATIONAHA.113.003046. Epub 2014 Jul 29.

PMID:
25074507
[PubMed - in process]
7.

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.

Stienen S, Salah K, Moons AH, Bakx AL, van Pol PE, Schroeder-Tanka JM, Voogel AJ, Keijer JT, Kortz RA, Dickhoff C, Meregalli PG, Tijssen JG, Pinto YM, Kok WE.

Am Heart J. 2014 Jul;168(1):30-6. doi: 10.1016/j.ahj.2014.04.008. Epub 2014 Apr 23.

PMID:
24952857
[PubMed - indexed for MEDLINE]
8.
9.

Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.

Kaul P, Reed SD, Hernandez AF, Howlett JG, Ezekowitz JA, Li Y, Zheng Y, Rouleau JL, Starling RC, O'Connor CM, Califf RM, Armstrong PW.

JACC Heart Fail. 2013 Dec;1(6):523-30. doi: 10.1016/j.jchf.2013.07.004. Epub 2013 Oct 23.

PMID:
24622005
[PubMed - in process]
10.

Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels.

Pan HY, Zhu JH, Gu Y, Yu XH, Pan M, Niu HY.

BMC Cardiovasc Disord. 2014 Mar 4;14:31. doi: 10.1186/1471-2261-14-31.

PMID:
24593826
[PubMed - in process]
Free PMC Article
11.

Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.

Tasal A, Demir M, Kanadasi M, Bacaksiz A, Vatankulu MA, Sahin DY, Eker RA, Bozkurt A, Acarturk E.

Med Sci Monit. 2014 Feb 19;20:276-82. doi: 10.12659/MSM.889767.

PMID:
24549281
[PubMed - in process]
Free PMC Article
12.

The role of albuminuria as a non-invasive marker for congestive acutely decompensated chronic heart failure and the spironolactone effect in elderly Portuguese: a non-randomized trial.

Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H.

Nephrology (Carlton). 2014 Mar;19(3):149-56. doi: 10.1111/nep.12188.

PMID:
24533733
[PubMed - in process]
13.

Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.

Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam F.

Am J Cardiol. 2014 Feb 15;113(4):691-6. doi: 10.1016/j.amjcard.2013.11.014. Epub 2013 Nov 23.

PMID:
24484862
[PubMed - indexed for MEDLINE]
14.

The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial.

Toma M, Ezekowitz JA, Bakal JA, O'Connor CM, Hernandez AF, Sardar MR, Zolty R, Massie BM, Swedberg K, Armstrong PW, Starling RC.

Eur J Heart Fail. 2014 Mar;16(3):334-41. doi: 10.1002/ejhf.19. Epub 2013 Dec 14.

PMID:
24464687
[PubMed - in process]
15.

Heart rate reduction with ivabradine in patients with acute decompensated systolic heart failure.

Sargento L, Satendra M, Longo S, Lousada N, dos Reis RP.

Am J Cardiovasc Drugs. 2014 Jun;14(3):229-35. doi: 10.1007/s40256-013-0060-1.

PMID:
24452599
[PubMed - in process]
16.

Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.

Chuang CP, Jong YS, Wu CY, Lo HM.

Am J Cardiol. 2014 Mar 1;113(5):845-50. doi: 10.1016/j.amjcard.2013.11.039. Epub 2013 Dec 12.

PMID:
24406111
[PubMed - indexed for MEDLINE]
17.

Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.

Naffaa M, Makhoul BF, Tobia A, Jarous M, Kaplan M, Aronson D, Saliba W, Azzam ZS.

Am J Emerg Med. 2014 Jan;32(1):44-9. doi: 10.1016/j.ajem.2013.10.002. Epub 2013 Oct 9.

PMID:
24210886
[PubMed - indexed for MEDLINE]
18.

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.

Salah K, Kok WE, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Damman P, Tijssen JG, Pinto YM.

Heart. 2014 Jan;100(2):115-25. doi: 10.1136/heartjnl-2013-303632. Epub 2013 Oct 31.

PMID:
24179162
[PubMed - indexed for MEDLINE]
Free Article
19.

Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.

Reed SD, Kaul P, Li Y, Eapen ZJ, Davidson-Ray L, Schulman KA, Massie BM, Armstrong PW, Starling RC, O'Connor CM, Hernandez AF, Califf RM.

J Card Fail. 2013 Sep;19(9):611-20. doi: 10.1016/j.cardfail.2013.07.003.

PMID:
24054337
[PubMed - indexed for MEDLINE]
20.

Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.

Matsue Y, Suzuki M, Nagahori W, Yoshida K, Onishi Y, Satoh Y, Ono Y, Nishioka T, Noda M, Sugi K, Torii S, Tejima T, Sakurada H, Yamaguchi S, Okishige K, Fujii H, Takahashi A.

Cardiovasc Drugs Ther. 2014 Feb;28(1):73-7. doi: 10.1007/s10557-013-6491-8.

PMID:
24048511
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk